Derazantinib dihydrochlorideProduct ingredient for Derazantinib

Show full entry for Derazantinib
Name
Derazantinib dihydrochloride
Drug Entry
Derazantinib

Derazantinib is under investigation in clinical trial NCT03230318 (Derazantinib in Subjects With FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma).

See full entry for Derazantinib
Accession Number
DBSALT003298
Structure
Synonyms
Not Available
UNII
U6B7J0L31Q
CAS Number
1821329-75-2
Not Available
Predicted Properties
Not Available